Clinical Trial Results: Safety, Tolerability, and Pharmacokinetic Study of TV-44749 in Chinese Patients With Schizophrenia [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety, tolerability, and pharmacokinetics of TV-44749 in Chinese patients with schizophrenia has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• TV-44749

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D LLC | Conditions: Schizophrenia | Phase 1 | Status: COMPLETED | Results posted: 2026-06-30